High-Volume Scanners
PRODUCTS
-
This versatile, compact powder filler designed to increase productivity, improve accuracy and enchance operator safety in lab and clinical manufacturing.
-
Streamline your Trial Master File (TMF) documentation and integrate with study sites to accelerate trial timelines.
Other eTMFs promise ease of use and seamless integration with the sites eISF, but they can’t deliver 100% adoption.
-
At inSeption Group, our Regulatory Operations team brings together specialized expertise, advanced technology, and seamless collaboration to get your submissions right—the first time.
-
With 30+ years of experience in viral vector development and manufacturing, we bring unmatched expertise as your trusted CDMO for AAV. From plasmids to fill/finish and advanced analytics, we provide true end-to-end support, accelerating your path to the clinic and beyond.
-
Our goal is to help your business succeed by working with you to streamline the FDA regulatory process. ProPharma’s team of science- based regulatory consultants commands an unparalleled breadth and depth of knowledge pertaining to FDA’s regulatory framework and can work with you to accomplish your business objectives.
WHITE PAPERS AND CASE STUDIES
-
How Digitized Protocols Are Accelerating Clinical Research
Digitized protocols, enhanced by artificial intelligence (AI), are transforming clinical trial operations by accelerating document generation, system integration, and trial optimization.
-
Office Of Naval Research Contract Leads To New Chlorine Sensor Technology
Developed from U.S. Office of Naval Research requirements, this multiparameter chlorine sensor offers extended maintenance-free operation, flow-independence, and automatic compensation for reliable, in-pipe monitoring.
-
How A CDMO Gained 40%+ Efficiency By Generating Automated APQRs
Discover how a CDMO's mounting challenges with manual product quality review (PQR) processes were resolved through the implementation of a next-generation cloud-based solution.
-
Patient Diversity: Identifying Challenges, Opportunities, And Best Practices
By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.
-
If You Can't Win The Game, Change It
Explore how eData sharing is used in the biopharma market, enabling standardized, collaborative supply chains that reduce risks and enhance visibility while improving capacity planning.
-
Writing An IND Module 3 For Cell And Gene Therapy Products
This whitepaper outlines the critical considerations for CGT Investigational New Drug (IND) Module 3, as well as how to avoid clinical holds and ensure regulatory readiness.
-
Expand Bandwidth With A Trusted Regulatory Writing Partner
Find out how a mid-size biotech lacking the bandwidth, expertise, and resources to independently handle its regulatory writing requirements overcame this challenge.
-
Increasing Batch Size And Reducing Cycle Times For A Biologic
JHS partnered with a global pharma company to optimize biologic production, increasing output by 50% and reducing batch release times by up to 30%.
-
A Synergy Of Excellence: Partnership During Unprecedented Times
Learn how a partner with the right experience and capabilities is crucial to support accelerated GMP manufacturing and ensure novel vaccines and therapeutics receive regulatory approval.
-
Cell And Gene Therapy Field Quiet In Q2
While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.
-
Leak Detection Program For Roswell, New Mexico
Harnessing satellite intelligence allows utilities to pinpoint hidden underground leaks with precision. By focusing field crews on high-probability clusters, municipalities can drastically reduce water loss, optimize repair budgets, and prioritize critical infrastructure replacement projects.
-
Impact Of Glycosylation On The Effector Functions Of Monoclonal Antibodies
In an example using rituximab and its biosimilars, explore the significance of minor differences of glycosylation in antibodies and its impact on their properties and functionality.
NEWS
-
Takara Bio USA And Hamilton Company Partner To Automate NGS Library Preparation3/30/2026
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company announced a development and co-marketing agreement to deliver integrated, automated next-generation sequencing (NGS) library preparation workflows to laboratories worldwide.
-
WEROCK Rugged Tablets: Now With Extended Range Scanner For Long Distances12/2/2025
WEROCK Technologies GmbH, manufacturer of rugged tablets, mobile data collection devices and industrial computers, is expanding the Rocktab Ultra series with an additional integrated barcode scanner option.
-
pdfFiller By airSlate Introduces Renewed Word To PDF Feature To Enhance Document Management Efficiency2/7/2025
pdfFiller, a leading document management platform, has unveiled a renewed and improved version of its Word to PDF conversion feature.
-
Samsung Launches Galaxy Tab Active5 In India: Rugged, 5G-Enabled Tablet Built For Enterprise Workforce8/18/2025
Samsung, India’s largest consumer electronics brand, today announced the launch of the Galaxy Tab Active5 Enterprise Edition in India, a rugged, enterprise-ready tablet engineered to empower businesses and professionals operating in high-intensity environments.
-
Gogo Plane Simple Ka-band Terminal Certified For Dassault Falcon 7X And 8X Aircraft9/30/2025
Gogo (NASDAQ: GOGO) announced today that the Gogo Plane Simple Ka-band tail mount antenna system has received European Union Aviation Safety Agency (EASA) supplemental type certification (STC) approvals for Dassault Falcon 7X and 8X aircraft.